Sarcoglycans in muscular dystrophy. - Wikidata - wikimedia - TriplyDB

Sarcoglycans in muscular dystrophy.

Sarcoglycans in muscular dystrophy.

http://www.wikidata.org/entity/Q33840940

about

Sarcoglycan subcomplex expression in normal human smooth muscle A method of utrophin up-regulation through RNAi-mediated knockdown of the transcription factor EN1 Biglycan binds to alpha- and gamma-sarcoglycan and regulates their expression during development Myoclonus-dystonia syndrome: epsilon-sarcoglycan mutations and phenotype Destabilization of the dystrophin-glycoprotein complex without functional deficits in alpha-dystrobrevin null muscle Differential expression of six genes and correlation with fatness traits in a unique broiler population Restoration of gamma-sarcoglycan localization and mechanical signal transduction are independent in murine skeletal muscle.Harnessing the potential of dystrophin-related proteins for ameliorating Duchenne's muscular dystrophy.Biglycan recruits utrophin to the sarcolemma and counters dystrophic pathology in mdx mice Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse.GlycoFish: a database of zebrafish N-linked glycoproteins identified using SPEG method coupled with LC/MS Secondary coronary artery vasospasm promotes cardiomyopathy progression.Protein defects in neuromuscular diseases.The sarcoglycan complex in striated and vascular smooth muscle.Sarcoglycanopathies: molecular pathogenesis and therapeutic prospects A novel isoform of delta-sarcoglycan is localized at the sarcoplasmic reticulum of mouse skeletal muscle.The sarcoglycan-sarcospan complex localization in mouse retina is independent from dystrophins.Nicotinic acetylcholine receptor stability at the NMJ deficient in α-syntrophin in vivo.Inhibition of proteasome activity promotes the correct localization of disease-causing alpha-sarcoglycan mutants in HEK-293 cells constitutively expressing beta-, gamma-, and delta-sarcoglycan.Animal models of muscular dystrophy Sub-physiological sarcoglycan expression contributes to compensatory muscle protection in mdx mice Overexpression of Galgt2 reduces dystrophic pathology in the skeletal muscles of alpha sarcoglycan-deficient mice The Classification, Natural History and Treatment of the Limb Girdle Muscular Dystrophies Milestones in dystonia.Ischemic postconditioning alters the gene expression pattern of the ischemic heart.Abnormalities in alpha-dystroglycan expression in MDC1C and LGMD2I muscular dystrophies.Update on the Genetics of Dystonia.Characterization of the ATP-hydrolysing activity of alpha-sarcoglycan.Smooth muscle cell-extrinsic vascular spasm arises from cardiomyocyte degeneration in sarcoglycan-deficient cardiomyopathy Engineered electrical conduction tract restores conduction in complete heart block: from in vitro to in vivo proof of concept.Biglycan regulates the expression and sarcolemmal localization of dystrobrevin, syntrophin, and nNOS.Structural and functional analysis of the sarcoglycan-sarcospan subcomplex.Several dystrophin-glycoprotein complex members are present in crude surface membranes but they are sodium dodecyl sulphate invisible in KCl-washed microsomes from mdx mouse muscle.delta- and gamma-Sarcoglycan localization in the sarcoplasmic reticulum of skeletal muscle.Sarcoglycan complex in human normal and pathological prostatic tissue: an immunohistochemical and RT-PCR study.Sarcoglycans in the normal and pathological breast tissue of humans: an immunohistochemical and molecular study.Deficiency of alpha-sarcoglycan differently affects fast- and slow-twitch skeletal muscles.A rare form of limb girdle muscular dystrophy (type 2E) seen in an Iranian family detected by autozygosity mapping.Characterization of the dystrophin-glycoprotein complex in airway smooth muscle: role of δ-sarcoglycan in airway responsiveness.A gain-of-glycosylation mutation associated with myoclonus-dystonia syndrome affects trafficking and processing of mouse ε-sarcoglycan in the late secretory pathway.

P2860

Q24302925-EAFF9BBD-4CDD-4EA3-91A9-87B1A5DAFFA4 Q24306528-F003EAEC-790B-4F17-9D49-A770583C17A6 Q24623422-48112641-EA8D-41E3-8FBC-03D8681388DF Q28204029-46E46B90-8F09-4568-9052-B300E9FE1BBA Q28473016-F2BD1CED-34C4-4DA1-A29E-63AC186B5080 Q33632745-7CFE27E3-38E2-47B1-867E-E2D84A8DCB2F Q33883334-AF742808-D39B-4E1F-9B6D-CCF47BBA4FD6 Q34285869-C356BBB5-18CE-4951-A08E-F8EF4A62421D Q34490767-A6D3868C-1996-48C4-9856-D03B51BEB149 Q34582428-8A4E03DD-C1AF-4319-AB4B-AA262A23DE86 Q35083499-F0625527-402F-444B-8A21-F7F76CCD3D08 Q35096094-962293A4-9635-4F4D-A26D-17287E50D9D2 Q35114795-0DE64860-05A2-4E2A-9FD3-78102BA764D7 Q35176895-91AE05CC-5BE5-48C1-BB73-08CB888E1913 Q35758335-763CF617-0837-4D11-BA59-B5C80D4C83CE Q35951670-1B0ACA7F-FBB6-44BC-8BC9-C7679B0E03C3 Q35951680-563D15FD-7484-4A14-877A-E5F4CD9D4597 Q36082812-933721D6-F302-4520-A4AF-A0E14F510422 Q36734894-7530B497-376A-4AF9-AC50-6B557F1FBD7B Q36915922-96A87B8A-A81E-4575-AE63-68A6017E7B24 Q37128346-FD573D35-3B0F-4082-A689-93B3C65FDFFF Q37257159-AA4825DF-CD43-4D43-85D4-D97F580F8461 Q37610524-9E50FC21-0EC9-4521-928A-3A174903BA7A Q37882600-04EA0F46-5F72-4689-80BA-383569564DC0 Q38481119-B6979AF6-D9FB-441B-81A3-0BAF7349D63C Q38584853-A52F981E-CA1E-438A-A494-F71C3D42E72E Q39173773-AE863436-31C1-42DE-A450-33346A866718 Q40576596-AE0A0935-6309-4586-889F-90AE118C352E Q40613995-830BBC1D-ACD0-49DD-8CBB-438357A654D8 Q41938602-0F7EFFC8-2540-4587-B05A-C4476BFF1CC9 Q42684588-9FE67B95-D033-48AE-8B24-E4CCD9E2C7DC Q42712728-4EA494B6-1F5D-47CB-B9B3-7DE45971FED0 Q43226891-F872F352-2E2B-4A1E-980B-43C7A618F2F0 Q43548166-D5D290BA-3B36-4A84-A4FC-60C075C26454 Q43950529-D28E336C-02A7-409C-81F8-6A640EFFAF57 Q45390318-A1168E4B-1158-4A10-B486-D9452A1284F4 Q46588754-AE59E1DC-4275-4E67-AF45-DA0B123DC199 Q48611801-B43451DE-4CEC-411E-8D95-FF0AFFDFBA33 Q51657614-4B248908-28CF-4C0B-AB26-EAF5160B326F Q53413310-1A081FF2-62CB-4418-9EF8-40EF4FDC4054

P2860

Sarcoglycans in muscular dystrophy.

http://www.wikidata.org/entity/Q33840940

description

2000 nî lūn-bûn

@nan

2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Sarcoglycans in muscular dystrophy.

@ast

Sarcoglycans in muscular dystrophy.

@en

type

label

Sarcoglycans in muscular dystrophy.

@ast

Sarcoglycans in muscular dystrophy.

@en

prefLabel

Sarcoglycans in muscular dystrophy.

@ast

Sarcoglycans in muscular dystrophy.

@en

P1433

Q33840940-8CF59FCF-5B2F-4B67-BC15-675681D8959F

P1476

Q33840940-13F384BE-3F97-4836-91B8-C33F79E0E5E2

P2093

Q33840940-48B55490-069E-439B-A15A-E052FC602020

Q33840940-DD256407-ED6D-4D00-804D-09277BB74672

Q33840940-F453582A-1BEA-4F97-B441-AAA3CD22573B

P2860

Q33840940-02523EC9-3765-4F62-B9E2-60B7B68460A4

Q33840940-030E2CA7-A4D0-4899-9546-6E00A53C0537

Q33840940-0379A2DF-CD0D-4F27-931F-6F4951795C33

Q33840940-0455B1DB-B08B-4EC2-8DC6-9D04D2124E3D

Q33840940-0647364B-1C19-4E5B-863A-AF70386F314D

Q33840940-08C9E19F-CEF0-4D63-B972-840E33F319F1

Q33840940-09F19A1D-B701-456C-8F57-F4600CD2FBB1

Q33840940-0B227D51-6BF3-40AD-B98F-5B93CBF9DC17

Q33840940-0E8F278D-B25A-4590-B36A-268739934637

Q33840940-112B4D18-6EA8-4DB7-8CD5-4ED628A11EC6

P304

Q33840940-2A2C965F-E727-47BF-9653-971A55B6BD20

P31

Q33840940-32052ACD-4202-461D-9E09-CA0DFBEBBB0E

P356

Q33840940-9AB7E279-6D20-4C46-89F3-506825E5715A

P433

Q33840940-3AFEFACF-7224-4961-A8C5-44C418533D18

P478

Q33840940-7FB3DB90-CD47-45EB-845E-E62B11122DB0

P577

Q33840940-370EB0EF-7602-4150-B807-D6A3F7D4817B

P698

Q33840940-5E29C99C-97A1-4445-A595-75FD5022B591

P356

4%3C167::AID-JEMT5%3E3.0.CO;2-T

P1433

Microscopy Research and Technique

P1476

Sarcoglycans in muscular dystrophy.

@en

P2093

Groh ME

http://www.w3.org/2001/XMLSchema#string

Hack AA

http://www.w3.org/2001/XMLSchema#string

McNally EM

http://www.w3.org/2001/XMLSchema#string

P2860

Stress-activated protein kinase-3 interacts with the PDZ domain of alpha1-syntrophin. A mechanism for specific substrate recognition

Autosomal recessive limb-girdle muscular dystrophy, LGMD2F, is caused by a mutation in the delta-sarcoglycan gene

Human epsilon-sarcoglycan is highly related to alpha-sarcoglycan (adhalin), the limb girdle muscular dystrophy 2D gene

Identification of a novel sarcoglycan gene at 5q33 encoding a sarcolemmal 35 kDa glycoprotein

Syntrophin binds to an alternatively spliced exon of dystrophin

Sarcospan, the 25-kDa transmembrane component of the dystrophin-glycoprotein complex

Beta-sarcoglycan: characterization and role in limb-girdle muscular dystrophy linked to 4q12

Cloning of human basic A1, a distinct 59-kDa dystrophin-associated protein encoded on chromosome 8q23-24

epsilon-Sarcoglycan, a broadly expressed homologue of the gene mutated in limb-girdle muscular dystrophy 2D

Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy

P304

167-180

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/(SICI)1097-0029(20000201/15)48:3/4<167::AID-JEMT5>3.0.CO;2-T

http://www.w3.org/2001/XMLSchema#string

P433

3-4

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P577

2000-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10679964

http://www.w3.org/2001/XMLSchema#string